https://ipharmag.com/article/novo-nordisk-ziltivekimab-halts-heart-trials iPharmag en 2026-09-08T05:06:11+00:00 Novo Nordisk Halts Two More Heart Trials of Its Anti-Inflammatory Drug https://ipharmag.com/article/gsk-hutchmed-attc-egfr-kras-cancer iPharmag en 2026-09-08T05:06:11+00:00 GSK Bets $110M on Hutchmed and a New Class of Dual-Target Cancer Drug https://ipharmag.com/article/eu-barcode-individual-dose-medicines iPharmag en 2026-09-08T05:06:11+00:00 Europe Weighs Putting a Barcode on Every Single Dose of Medicine https://ipharmag.com/article/atomvie-radiopharmaceutical-facility-ontario iPharmag en 2026-09-08T05:06:11+00:00 A $160M Ontario Plant Bets Big on Radioactive Cancer Drugs https://ipharmag.com/article/aptar-aceso-inhaled-cystic-fibrosis-act101 iPharmag en 2026-09-08T05:06:11+00:00 An Inhaled RNA Drug Aims to Fix Cystic Fibrosis a Step Earlier https://ipharmag.com/article/tyrosine-brain-supplement-lifespan-men-study iPharmag en 2026-09-07T02:15:22+00:00 A Study Tied Higher Tyrosine Levels to Shorter Lifespan in Men — With Big Caveats https://ipharmag.com/article/medicines-discovery-catapult-flip-nascent-biotech iPharmag en 2026-09-07T02:15:22+00:00 UK Innovation Body Backs Two Biotechs Chasing Autoimmune and Aging Diseases https://ipharmag.com/article/latam-fingers-lifestyle-cognition-dementia-trial iPharmag en 2026-09-07T02:15:22+00:00 A Coached Lifestyle Program Boosted Cognition 55% More Than Health Advice Alone https://ipharmag.com/article/breast-cancer-dormant-cells-protective-shields iPharmag en 2026-09-07T02:15:22+00:00 Breast Cancer Cells Survive Treatment by Hiding Behind Cellular ‘Shields’ https://ipharmag.com/article/american-regent-epinephrine-injection-recall-particulate iPharmag en 2026-09-07T02:15:22+00:00 American Regent Recalls Epinephrine Injection Vials Over Cracks and Particles